JANX vs SPTX: stock comparison and AI forecast
Janux Therapeutics, Inc. (JANX) and Seaport Therapeutics, Inc. (SPTX) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
JANX Janux Therapeutics, Inc.
- Market Cap
- $982M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
SPTX Seaport Therapeutics, Inc.
- Price
- $20.39 +25.9% · 6M
- Market Cap
- $1.09B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- SPTX is 1.1 times larger than JANX by market capitalization ($1.09B against $982M).
- JANX carries 0.08 times debt per unit of equity, against 0.05 times for SPTX.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | JANX | SPTX |
|---|---|---|
| Market Cap | $982M | $1.09B |
| P/B Ratio | 1.08x | 2.75x |
| EPS | $-1.78 | – |
| Book Value/Share | $14.91 | $7.42 |
| Revenue/Share | $0.32 | – |
| FCF/Share | $-0.89 | – |
Profitability & Margins
| Metric | JANX | SPTX |
|---|---|---|
| ROE | -10.9% | – |
| ROA | -10.2% | – |
| ROIC | -15.0% | – |
| Operating Margin | -713.6% | – |
| Net Margin | -510.6% | – |
| EBT Margin | -713.6% | – |
Financial Health
| Metric | JANX | SPTX |
|---|---|---|
| Current Ratio | 17.69x | 17.48x |
| D/E Ratio | 0.08x | 0.05x |
| Financial Leverage | 1.08x | 1.05x |
| Working Capital | $905M | $282M |
Cash Flow
| Metric | JANX | SPTX |
|---|---|---|
| Operating Cash Flow | -$54M | – |
| Free Cash Flow | -$54M | – |
| Capital Spending | -$580K | – |
| FCF/Sales | -276.9% | – |
| CapEx/Sales | 3.0% | – |
Operational Efficiency
| Metric | JANX | SPTX |
|---|---|---|
| Asset Turnover | 0.02x | – |
| Receivables Turnover | 47.6x | – |
| Fixed Assets Turnover | 7.0x | – |
| Days Sales Outstanding | 8 days | – |
Income Statement
| Metric | JANX | SPTX |
|---|---|---|
| Total Revenue | $20M | – |
| Operating Income | -$140M | – |
| Net Income | -$100M | – |
| R&D Expense | $120M | – |
Dividend & Shareholder Information
| Metric | JANX | SPTX |
|---|---|---|
| Shares Outstanding | 61M | 54M |
JANX vs SPTX: stock comparison and AI forecast
Which is bigger, JANX or SPTX?
SPTX is 1.1 times larger than JANX by market capitalization ($1.09B against $982M).
Which one does Intratio's AI model rank higher, JANX or SPTX?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.